Investing.com - Evoke Pharma (NASDAQ: EVOK) reported third quarter EPS of $-0.9400, $0.95 worse than the analyst estimate of $0.0100. Revenue for the quarter came in at $2.65M versus the consensus estimate of $4.1M.
Evoke Pharma's stock price closed at $5.65. It is up 2.7800% in the last 3 months and down -63.2000% in the last 12 months.
Evoke Pharma saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Evoke Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Evoke Pharma's Financial Health score is "good performance".
Check out Evoke Pharma's recent earnings performance, and Evoke Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar